| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |